BETHESDA, Md.--(BUSINESS WIRE)--Jun 25, 2009 - The use of adiponectin, a hormone derived from fat cells, was confirmed as a robust biomarker predictive of glycemic efficacy in Type 2 diabetes and healthy subjects, after treatment with peroxisome. FDA Issues Safety Communication about an Ongoing Review of Stimulant Medications Used in Children with ADHD
More Info